As of 2026-05-26, the EV/EBITDA ratio of Alembic Pharmaceuticals Ltd (APLLTD.NS) is 13.67. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. APLLTD.NS's latest enterprise value is 163,381.10 mil INR. APLLTD.NS's TTM EBITDA according to its financial statements is 11,954.90 mil INR. Dividing these 2 quantities gives us the above APLLTD.NS EV/EBITDA ratio.
| Range | Selected | |
| Trailing P/E multiples | 14.3x - 18.4x | 16.0x |
| Forward P/E multiples | 14.2x - 18.9x | 16.3x |
| Fair Price | 800.83 - 1,339.02 | 1,025.43 |
| Upside | 5.1% - 75.7% | 34.5% |
| Date | EV/EBITDA |
| 2026-05-20 | 13.46 |
| 2026-05-19 | 13.51 |
| 2026-05-18 | 13.07 |
| 2026-05-15 | 13.97 |
| 2026-05-14 | 14.04 |
| 2026-05-13 | 13.79 |
| 2026-05-12 | 13.71 |
| 2026-05-11 | 14.12 |
| 2026-05-08 | 14.07 |
| 2026-05-07 | 13.84 |
| 2026-05-06 | 14.04 |
| 2026-05-05 | 13.79 |
| 2026-05-04 | 13.74 |
| 2026-04-30 | 13.51 |
| 2026-04-29 | 13.65 |
| 2026-04-28 | 13.63 |
| 2026-04-27 | 13.66 |
| 2026-04-24 | 13.51 |
| 2026-04-23 | 13.88 |
| 2026-04-22 | 13.72 |
| 2026-04-21 | 13.71 |
| 2026-04-20 | 13.59 |
| 2026-04-17 | 13.97 |
| 2026-04-16 | 13.46 |
| 2026-04-15 | 13.14 |
| 2026-04-13 | 12.91 |
| 2026-04-10 | 13.01 |
| 2026-04-09 | 12.97 |
| 2026-04-08 | 13.20 |
| 2026-04-07 | 12.53 |
| 2026-04-06 | 11.94 |
| 2026-04-02 | 11.92 |
| 2026-04-01 | 12.20 |
| 2026-03-30 | 12.07 |
| 2026-03-27 | 12.15 |
| 2026-03-25 | 12.56 |
| 2026-03-24 | 12.18 |
| 2026-03-23 | 11.82 |
| 2026-03-20 | 12.43 |
| 2026-03-19 | 12.02 |
| 2026-03-18 | 12.24 |
| 2026-03-17 | 12.07 |
| 2026-03-16 | 12.29 |
| 2026-03-13 | 12.29 |
| 2026-03-12 | 12.74 |
| 2026-03-11 | 12.74 |
| 2026-03-10 | 12.87 |
| 2026-03-09 | 12.69 |
| 2026-03-06 | 12.81 |
| 2026-03-05 | 12.68 |